Peptide aptamers: Specific inhibitors of protein function

被引:70
作者
Hoppe-Seyler, F [1 ]
Crnkovic-Mertens, I [1 ]
Tomai, E [1 ]
Butz, K [1 ]
机构
[1] Deutsch Krebsforschungszentrum, Programm Infekt & Krebs, D-69120 Heidelberg, Germany
关键词
peptide aptamers; yeast two-hybrid; protein-protein interaction; protein therapy; protein transduction; drug design; protein array;
D O I
10.2174/1566524043360519
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In recent years, peptide aptamers have emerged as novel molecular tools that are useful for both basic and applied aspects of molecular medicine. Due to their ability to specifically bind to and inactivate a given target protein at the intracellular level, they provide a new experimental strategy for functional protein analyses, both in vitro and in vivo. In addition, by using peptide aptamers as "pertubagens", they can be employed for genetic analyses, in order to identify biochemical pathways, and their components, that are associated with the induction of distinct cellular phenotypes. Furthermore, peptide aptamers may be developed into diagnostic tools for the detection of a given target protein or for the generation of high-throughput protein arrays. Finally, the peptide aptamer technology has direct therapeutic implications. Peptide aptamers can be used in order to validate therapeutic targets at the intracellular level. Moreover, the peptide aptamer molecules themselves should possess therapeutic potential, both as lead structures for drug design and as a basis for the development of protein drugs.
引用
收藏
页码:529 / 538
页数:10
相关论文
共 47 条
[1]   Green fluorescent protein as a scaffold for intracellular presentation of peptides [J].
Abedi, MR ;
Caponigro, G ;
Kamb, A .
NUCLEIC ACIDS RESEARCH, 1998, 26 (02) :623-630
[2]   Isolation of peptide aptamers that inhibit intracellular processes [J].
Blum, JH ;
Dove, SL ;
Hochschild, A ;
Mekalanos, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) :2241-2246
[3]   THE NEUROPEPTIDE HEAD ACTIVATOR LOSES ITS BIOLOGICAL-ACTIVITY BY DIMERIZATION [J].
BODENMULLER, H ;
SCHILLING, E ;
ZACHMANN, B ;
SCHALLER, HC .
EMBO JOURNAL, 1986, 5 (08) :1825-1829
[4]   Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells [J].
Buerger, C ;
Nagel-Wolfrum, K ;
Kunz, C ;
Wittig, I ;
Butz, K ;
Hoppe-Seyler, F ;
Groner, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37610-37621
[5]   Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein [J].
Butz, K ;
Denk, C ;
Ullmann, A ;
Scheffner, M ;
Hoppe-Seyler, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6693-6697
[6]   Peptide aptamers targeting the hepatitis B virus core protein:: a new class of molecules with antiviral activity [J].
Butz, K ;
Denk, C ;
Fitscher, B ;
Crnkovic-Mertens, I ;
Ullmann, A ;
Schröder, CH ;
Hoppe-Seyler, F .
ONCOGENE, 2001, 20 (45) :6579-6586
[7]   Emerging roles for E2F: Beyond the G1/S transition and DNA replication [J].
Cam, H ;
Dynlacht, BD .
CANCER CELL, 2003, 3 (04) :311-316
[8]   Transdominant genetic analysis of a growth control pathway [J].
Caponigro, G ;
Abedi, MR ;
Hurlburt, AP ;
Maxfield, A ;
Judd, W ;
Kamb, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7508-7513
[9]   The selection of intracellular antibodies [J].
Cattaneo, A ;
Biocca, S .
TRENDS IN BIOTECHNOLOGY, 1999, 17 (03) :115-121
[10]   An artificial cell-cycle inhibitor isolated from a combinatorial Library [J].
Cohen, BA ;
Colas, P ;
Brent, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14272-14277